Font Size:
a
A
A
Keyword [anti tuberculosis drugs]
Result: 41 - 60 | Page: 3 of 4
41.
Study On The Correlation Between Allergy Constitution And Adverse Reactions Of Anti-tuberculosis Drugs
42.
Analysis Of Second-Line Anti-Tuberculosis Drug Resistance Characteristics And Associated-Genes Of Clinical Mycobacterium Tuberculosis Isolates From Hebei Province
43.
Drug-Induced Hypersensitivity Syndrome Induced By Anti-Tuberculosis Drugs: Report Cases And Literature Review
44.
Research Of Genetic Polymorphism Of GSTs And Liver Injury Induced By Anti-tuberculosis Drugs
45.
Attenuating Effects Of Hugan Yifei Recipe On Anti-tuberculosis Drugs And Preliminary Research On The Material Basis
46.
Construction Of The In Vitro Evaluation Strain Panel For Anti-tuberculosis Drugs
47.
A Mechanism Underlies The Hepatotoxicity Of Anti-tuberculosis Drugs Mediated By Pathway Of Fxr-bile Acid Based On Targeted Metabolomics
48.
Characterization of the enzymes involved in the methylerythritol phosphate pathway with a view to development of broad-spectrum antibiotics including anti-tuberculosis drugs
49.
Clinical Analysis Of 137 Cases Of Drug-induced Liver Injury Caused By Anti-tuberculosis Drugs
50.
Analysis Of Risk Factors For Anti-tuberculosis Drug-induced Liver Injury In Patients With Primary Anti-tuberculosis Treatment
51.
Based On Farnesol X Receptor To Explore The Mechanism Of Liver Injury Caused By Quadruple Anti-tuberculosis Drugs
52.
Relationship Between Xanthine Oxidase Gene Polymorphism And Adverse Reactions Induced By Anti-tuberculosis Drugs
53.
Effect Of Anti-tuberculosis Drugs On Gut Microbiota And Improvement Effect Of Lactobacillus Casei Supplement
54.
Study On The Prevention And Therapeutic Effects Of Yinzhihuang Oral Liquid On Anti-Tuberculosis Drugs Induced Liver Injury
55.
Damage Effects Of Lfliu Combined With Nanoparticles Loaded With Different Anti-tuberculosis Drugs On Mycobacterium Smegmatis And Biofilms
56.
Study On The Molecular Mechanism Of Encoding Ectodysplasin α Receptor Associated Death Domain For Anti-tuberculosis Drugs-induced Liver Injury In Tuberculosis Patients
57.
Evidence-based Evaluation Of Glycyrrhizic Acid Preparations In The Prevention And Treatment Of Firstline Anti-tuberculosis Drug-induced Liver Injury And Its Mechanism Based On Gut Microbiota
58.
GLDH Combined With Inflammatory Cytokines As Biomarkers Of Anti-tuberculosis Drugs Induced Liver Injury
59.
Study On Dietary Patterns And Serum Energy Metabolic Markers Associated With The Risk Of Liver Injury Induced By Anti-tuberculosis Drugs
60.
Studies On The Mechanism Of Sterol Analogue-Lithocholic Acid Sulfonylimide Adenosine Inhibit Mycobacteria And Its Drug Combination Effect
<<First
<Prev
Next>
Last>>
Jump to